Bayer said on Tuesday it had secured the rights to an experimental breast cancer drug developed by U.S. biotech firm Systems Oncology LLC in a deal worth up to $370 million.
Minneapolis-based fleet analytics and benchmarking company Utilimarc has joined Smith System, the developer of the Smith5Keys ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback